View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry

Blog

FDA’s Dr Richard Moscicki Confirmed for the Boston Chief Medical Officer’s Summit


  • April 3, 2015

  • The Conference Forum is pleased to announce that Dr. Richard Moscicki, Deputy Center Director for Science Operations for the FDA is joining the Chief Medical Officer Summit. He joins the CMO Summit to help CMOs explore alternative regulatory pathways. Trends and case examples will be presented on:

    • Breakthrough designation
    • Fast Track
    • Priority Review
    • Orphan Designations
    • Accelerated Approval
    • Other initiatives to early access to medicines

    “We are very excited to have Dr. Moscicki’s participation. It will allow our CMO attendees face-to-face time with the FDA and to engage in Q&A. With Dr. Moscicki’s guidance, our attendees will leave the Summit better armed with the knowledge required to best position their drug for approval” said Jennifer Moran, Conference Producer, CMO Summit.

    The Chief Medical Officer Summit brings CMOs together to help CMO’s

    • Drive value in their companies
    • Navigate the clinical and regulatory pathways
    • Support business development
    • Manage the expectations of the CEO and board
    • Provide strategic insights in corporate investments
    • Manage outsourcing
    • Share best practices in medical affairs and safety across therapeutic areas
    • Transitioning company growth to include staffing, culture and organizational structure
    • Prepare for exits

    Click here to Read Dr. Moscicki’s full bio.
    Click here for more information on the CMO Summit.